TY - JOUR
T1 - Systematic review of indoor residual spray efficacy and effectiveness against Plasmodium falciparum in Africa.
AU - Sherrard-Smith, Ellie
AU - Griffin, Jamie T.
AU - Winskill, Peter
AU - Corbel, Vincent
AU - Pennetier, Cédric
AU - Djénontin, Armel
AU - Moore, Sarah
AU - Richardson, Jason H.
AU - Müller, Pie
AU - Edi, Constant
AU - Protopopoff, Natacha
AU - Oxborough, Richard
AU - Agossa, Fiacre
AU - N’Guessan, Raphael
AU - Rowland, Mark
AU - Churcher, Thomas S.
PY - 2018/11/26
Y1 - 2018/11/26
N2 - Indoor residual spraying (IRS) is an important part of malaria control. There is a growing list of insecticide classes; pyrethroids remain the principal insecticide used in bednets but recently, novel non-pyrethroid IRS products, with contrasting impacts, have been introduced. There is an urgent need to better assess product efficacy to help decision makers choose effective and relevant tools for mosquito control. Here we use experimental hut trial data to characterise the entomological efficacy of widely-used, novel IRS insecticides. We quantify their impact against pyrethroid-resistant mosquitoes and use a Plasmodium falciparum transmission model to predict the public health impact of different IRS insecticides. We report that long-lasting IRS formulations substantially reduce malaria, though their benefit over cheaper, shorter-lived formulations depends on local factors including bednet use, seasonality, endemicity and pyrethroid resistance status of local mosquito populations. We provide a framework to help decision makers evaluate IRS product effectiveness.
AB - Indoor residual spraying (IRS) is an important part of malaria control. There is a growing list of insecticide classes; pyrethroids remain the principal insecticide used in bednets but recently, novel non-pyrethroid IRS products, with contrasting impacts, have been introduced. There is an urgent need to better assess product efficacy to help decision makers choose effective and relevant tools for mosquito control. Here we use experimental hut trial data to characterise the entomological efficacy of widely-used, novel IRS insecticides. We quantify their impact against pyrethroid-resistant mosquitoes and use a Plasmodium falciparum transmission model to predict the public health impact of different IRS insecticides. We report that long-lasting IRS formulations substantially reduce malaria, though their benefit over cheaper, shorter-lived formulations depends on local factors including bednet use, seasonality, endemicity and pyrethroid resistance status of local mosquito populations. We provide a framework to help decision makers evaluate IRS product effectiveness.
U2 - 10.1038/s41467-018-07357-w
DO - 10.1038/s41467-018-07357-w
M3 - Article
SN - 2041-1723
VL - 9
SP - 4982
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 4982
ER -